Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM57C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,071
Award facts
- Contract value 100% obligated
- $10,070.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,070.54 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Renflexis 100 mg vials with an ultimate completion date of February 17, 2026.
The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FM57C?
SPE2DR26FM57C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 13, 2026.
How much is contract SPE2DR26FM57C worth?
The government has obligated $10,071 on SPE2DR26FM57C.
Is contract SPE2DR26FM57C an order under another contract?
Yes. SPE2DR26FM57C is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM57C competed?
The extent of competition for SPE2DR26FM57C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award